Surgical Science Sweden AB Intrinsic Value
SUS.XSTO
Choose a model
Each card values Surgical Science Sweden AB a different way, shown at our starting inputs. Pick one to see and change how it works.
Set your assumptions
Surgical Science Sweden AB on earnings: earnings per share grow for a few years, then the stock trades at a normal price-to-earnings multiple.
Years to project
Growth of earnings per share
Earnings per share; starts at its own recent growth
Exit P/E
Starts at the average of its 5-year median P/E, today's and a mature 18
Your desired return
Margin of safety
More
Your buy price
The expected return is measured from it; starts at today's price
How it's worked out
Today's earnings per share
Diluted, last twelve months, as filed
kr 1.83
Earnings in 2031
Grows 0.5% a year for 5 years
kr 1.88
Price in 2031
kr 1.88 × 30.0 P/E
kr 56.29
Worth today
÷ 1.10^5: your 10% a year, taken back out
kr 34.95
Fair value
The most you can pay and still earn 10% a year
kr 34.95
Buy below
Fair value minus your 25% margin of safety
kr 26.21
Paying kr 59.05 instead gives -1.0% a year. Every rule is on the methodology page.
Outcome
What your assumptions give, and the path from today's price.
Fair value
kr 34.95
Expected return
-1.0% a year
Future price, 2031
kr 56.29
Buy below
kr 26.21
Price 69% above fair valuePrice kr 59.05, at your 10% return
Projection
Solid blue: the price at each year end. Dashed blue: from today's price to the 2031 price. Green: from the fair value, rising at your 10% a year to the same end point; buy at or below it and you earn at least that. Every rule is on the methodology page. A model, not a forecast or advice.
Build your own intrinsic value for Surgical Science Sweden AB. Start from three cases based on the company's own filings, then change any number to match your view.
Conservative
kr 58.48
1% below the priceof kr 59.05
Buy below kr 43.86 for a 25% safety margin
Your assumptions
Base
kr 97.32
65% above the priceof kr 59.05
Buy below kr 72.99 for a 25% safety margin
Your assumptions
Optimistic
kr 175.87
198% above the priceof kr 59.05
Buy below kr 131.90 for a 25% safety margin
Your assumptions
Where today's price sits
Today's price falls inside the modelled range.
Verdict
Today's price sits inside the range, 65% below the base case. Whether that is a discount depends entirely on the base case growth holding.
Base free cash flow
kr 83M
Trailing twelve months
Historical FCF CAGR
+27.5%
Across 6 reported periods
Market implies
10.1%
Growth needed at 8% WACC
Terminal value share
69%
Of the base case valuation
Growth needed to justify today's price
At a 8.0% discount rate, today's price already assumes 10.1% annual free cash flow growth for ten years. Your base case assumes 20.0%, so you are forecasting more growth than the price requires.
Curve holds terminal growth at 2.5%, years 6 to 10 at half the first-stage rate, and applies no safety margin.
Free cash flow history
The most recent period is the base every projection starts from. Compounded, that history is +27.5% a year.
Surgical Science Sweden AB (SUS.XSTO) intrinsic value and fair value
The calculator grows one of Surgical Science Sweden AB's per-share figures (earnings, free cash flow, revenue, book value or dividends) for a few years, puts an exit multiple on it, and discounts the result back at the yearly return you want. The answers below use its starting inputs for SUS.XSTO; this is analysis, not investment advice.
Frequently asked
What is Surgical Science Sweden AB's (SUS.XSTO) intrinsic value?+
With Intrinsiqq's starting inputs, Surgical Science Sweden AB's fair value is about kr 34.95 a share, based on its earnings per share. That assumes earnings per share of kr 1.83 grows about 0.5% a year for 5 years, the stock then trades at 30.0 times earnings, and you want a 10.0% yearly return. On its other figures: free cash flow kr 36.75, revenue kr 272.45. Every input can be changed on the page; the result is a model, not a forecast.
Is Surgical Science Sweden AB overvalued?+
At kr 59.05, the price is 69% above that fair value of kr 34.95, and buying at today's price would return about -1.0% a year if those inputs hold. Whether that is cheap or dear depends on whether you believe the growth and the exit multiple, which is what the calculator lets you test. This is analysis from company filings, not investment advice.
What growth does the Surgical Science Sweden AB valuation assume?+
Earnings per share grows about 0.5% a year to start, its own recent growth per share (three years for a company not yet profitable, five otherwise). The exit multiple starts at a default.
What is a good margin of safety for Surgical Science Sweden AB?+
A margin of safety is the cushion you want below the fair value before buying, in case the inputs are wrong. The calculator uses 25%, which puts the buy-below price at kr 26.21. Less predictable businesses deserve a wider cushion, or a higher desired return.
Peers
Health Information Services · Pick stocks to compare with SUS.XSTO
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing SUS.XSTO
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.